找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Disease Recurrence After Liver Transplantation; Natural History, Tre Paul J. Thuluvath Book 2016 Springer Science+Business Media New York 2

[復(fù)制鏈接]
樓主: otitis-externa
11#
發(fā)表于 2025-3-23 11:14:35 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:59 | 只看該作者
13#
發(fā)表于 2025-3-23 19:12:16 | 只看該作者
14#
發(fā)表于 2025-3-23 22:22:50 | 只看該作者
15#
發(fā)表于 2025-3-24 03:28:08 | 只看該作者
Treatment of Recurrent Hepatitis C,e the natural history of recurrent hepatitis. Preliminary studies indicate that approximately 90 % of people with recurrent HCV could be cured with a combination of direct acting antiviral drugs with minimal side effects.
16#
發(fā)表于 2025-3-24 08:52:59 | 只看該作者
17#
發(fā)表于 2025-3-24 12:01:43 | 只看該作者
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation,s are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
18#
發(fā)表于 2025-3-24 17:21:01 | 只看該作者
19#
發(fā)表于 2025-3-24 19:51:58 | 只看該作者
Recurrence of HCC When Transplanted Outside Milan Criteria,r LT. The main disadvantage of this set of criteria is that it is relatively restrictive. Several attempts have been made to expand these criteria to include tumors of greater number and size. The model for end-stage liver disease (MELD) prioritization system has utilized the Milan criteria since ad
20#
發(fā)表于 2025-3-24 23:09:01 | 只看該作者
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation, the Milan criteria have been shown to be 8–15 % and higher in those patients beyond the Milan criteria. The value of adjuvant therapy using systemic cytotoxic chemotherapy after LT has been disappointing. Sorafenib has been used for treatment in recurrent HCC after LT, and the data of safety and ef
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 22:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
云林县| 彭泽县| 宁安市| 巴彦县| 离岛区| 冷水江市| 湖北省| 巴林左旗| 漳浦县| 丹东市| 新龙县| 秦安县| 石阡县| 白山市| 峨眉山市| 安化县| 赣州市| 临夏市| 察隅县| 广西| 漳平市| 朔州市| 贵港市| 秦皇岛市| 田东县| 寻甸| 哈尔滨市| 红河县| 灌云县| 威信县| 永清县| 永吉县| 平舆县| 武胜县| 沿河| 芮城县| 苏尼特左旗| 七台河市| 深圳市| 台湾省| 晴隆县|